Company Overview and News

0
Groupe ERAMET : ERAMET annonce la prise de contrôle de la société Mineral Deposits Limited

2018-07-11 globenewswire
ERAMET annonce ce jour détenir 63,87 % du capital de la société Mineral Deposits Limited (MDL) dans le cadre de son offre publique d'achat (Offre). Le 10 juillet 2018, le Conseil d'Administration de MDL a par ailleurs recommandé à l'unanimité aux actionnaires de la société d'accepter l'Offre. MDL a également confirmé que l'ensemble de ses administrateurs ont l'intention d'accepter l'Offre en apportant les actions qu'ils détiennent.
MNLDF MDL

0
ERAMET Group: ERAMET announces that it has acquired a controlling interest in Mineral Deposits Limited

2018-07-11 globenewswire
ERAMET announces today that it now holds a relevant interest in 63.87% of the shares of Mineral Deposits Limited (MDL) in the framework of its all-cash takeover offer (Offer).
MNLDF MDL

0
Deals of the day-Mergers and acquisitions

2018-07-10 reuters
July 10 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:
MNLDF CHLKF PFD SFTBF CTTAF XRX MDL FUJIF YAHOF 0941 4901 CHL GTY 4689 CTTAY YAHOY 9984 FUJIY SFTBY CMBGF

0
Groupe ERAMET : Levée des conditions de l'Offre Publique d'Achat sur les actions de la société Mineral Deposits Limited (MDL)

2018-07-05 globenewswire
Groupe ERAMET : Levée des conditions de l'Offre Publique d'Achat sur les actions de la société Mineral Deposits Limited (MDL)
MNLDF MDL

0
ERAMET Group: Offer for Mineral Deposits Limited (MDL) shares declared unconditional

2018-07-05 globenewswire
Following its press releases dated 27 April 2018, 14 May 2018, and 13 June 2018, ERAMET announces today that its all-cash offer (Offer) for all of the fully-paid ordinary shares in MDL that it does not already own is declared unconditional.
MNLDF MDL

0
Board Update

2018-06-26 globenewswire
Kenmare Resources plc is pleased to announce that Mr Clever Fonseca has agreed to join the Company's Board as an independent Non-Executive Director, effective 1 July 2018. Mr Fonseca has worked in the titanium industry for over thirty five years and has extensive knowledge and board-level management experience of mineral sands mining.
MNLDF MDL KMR KMRPF

86
Deals of the day-Mergers and acquisitions

2018-06-14 reuters
June 14 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday:
MNLDF FOX SRX SXMDF CCV CMCSA RCL SRXTY CCZ 532843 MDL ERA HMBH ABCB VAR FORTIS CCV.CL FORTISMLR FOXA CMCSK 523696 DIS

42
Deals of the day-Mergers and acquisitions

2018-06-13 reuters
June 13 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Wednesday:
MNLDF BGX GTY TWX BGLF BX IOF TWC APA MDL BGB

0
Groupe ERAMET : augmentation à 1,75 dollar australien, prix final et définitif de l'Offre Publique d'Achat sur les actions de la société Mineral Deposits Limited (MDL)

2018-06-12 globenewswire
Groupe ERAMET : augmentation à 1,75 dollar australien, prix final et définitif[1] de l'Offre Publique d'Achat sur les actions de la société Mineral Deposits Limited (MDL)
MNLDF MDL

0
ERAMET Group: Offer for Mineral Deposits Limited (MDL) shares increased to A$1.75 as last and final

2018-06-12 globenewswire
ERAMET Group: Offer for Mineral Deposits Limited (MDL) shares increased to A$1.75 as last and final[1]
MNLDF MDL

16
European Electric Metals Reports on Advanced Stage Portugal Copper Project

2018-05-23 globenewswire
VANCOUVER, British Columbia, May 23, 2018 (GLOBE NEWSWIRE) -- European Electric Metals Inc. (TSX-V:EVX) (“EVX” or “the Company”) is pleased to announce that it has signed an agreement to acquire an exploration application in Portugal for an advanced stage copper asset with historic production.
MNLDF RTPPF RIO RIO LUNMF RIO PWRMF RTNTF LUNCF LUN EVXXF MDL

0
ERAMET Group: Opening of the takeover offer for Mineral Deposits Limited

2018-05-14 globenewswire
Following its press release dated 27 April 2018, ERAMET today announces that its off-market takeover offer to acquire all of the issued shares in Mineral Deposits Limited (MDL) that it does not already own for A$1.46 cash per share (Offer) is now open for acceptance by MDL shareholders.
MNLDF MDL

0
Groupe Eramet : Ouverture de l'offre publique d'achat sur les actions de la Société Mineral Deposits Limited

2018-05-14 globenewswire
Groupe ERAMET : Ouverture de l'offre publique d'achat sur les actions de la société Mineral Deposits Limited
MNLDF MDL

0
Mineral Deposits chairman slams Eramet offer

2018-05-10 australianmining.com.au
Mineral Deposits (MDL) chairman Nic Limb has responded negatively to Eramet’s unsolicited offer to acquire MDL for $287.5 million at $1.46/share, calling the offer “grossly inadequate” and urging shareholders to reject it.
MNLDF MDL

0
Mineral Deposits surges after takeover bid from French giant ERAMET

2018-04-27 proactiveinvestors.com.au
Mineral Deposits Limited (ASX:MDL) is a leading ASX gainer after fielding a takeover offer from French-based, global mining company ERAMET SA (FRA:ER7).
MNLDF MDL ERA

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...